Scale rating variability in Alzheimer's disease clinical trials: A literature review
De Santi, Susan, Weber, Christopher J, Kirby, Louis C, Williams, Janet B.W
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
The MARQ-AD: A new measure of interview quality in Alzheimer's disease trials
Weber, Christopher J, De Santi, Susan, Kirby, Louis C, Williams, Janet B.W
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study
Tepper, Stewart J, Albrecht, Detlef, Ailani, Jessica, Kirby, Louis, Strom, Shannon, Rapoport, Alan M
Published in CNS drugs (07.10.2024)
Published in CNS drugs (07.10.2024)
Get full text
Journal Article
A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
Morimoto, Bruce H., Schmechel, Don, Hirman, Joe, Blackwell, Andrew, Keith, Julian, Gold, Michael
Published in Dementia and geriatric cognitive disorders (01.05.2013)
Published in Dementia and geriatric cognitive disorders (01.05.2013)
Get full text
Journal Article
P4‐181: The lympro® test: A fit for purpose validation of a flow cytometric assay to assess lymphocyte proliferation in peripheral blood lymphocytes in Alzheimer's disease
Jorgensen, Paul, Kirby, Louis, Bushnell, Timothy, Bier, Colin
Published in Alzheimer's & dementia (01.07.2015)
Published in Alzheimer's & dementia (01.07.2015)
Get full text
Journal Article
The lympro® test: A fit for purpose validation of a flow cytometric assay to assess lymphocyte proliferation in peripheral blood lymphocytes in Alzheimer’s disease
Jorgensen, Paul, Kirby, Louis, Bushnell, Timothy, Bier, Colin
Published in Alzheimer's & dementia (01.07.2015)
Published in Alzheimer's & dementia (01.07.2015)
Get full text
Journal Article
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
THAL, Leon J, FERRIS, Steven H, REINES, Scott A, KIRBY, Louis, BLOCK, Gilbert A, LINES, Christopher R, YUEN, Eric, ASSAID, Christopher, NESSLY, Michael L, NORMAN, Barbara A, BARANAK, Christine C
Published in Neuropsychopharmacology (New York, N.Y.) (01.06.2005)
Published in Neuropsychopharmacology (New York, N.Y.) (01.06.2005)
Get full text
Journal Article
Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
Vinik, Aaron I., Tuchman, Michael, Safirstein, Beth, Corder, Clinton, Kirby, Louis, Wilks, Kerri, Quessy, Steve, Blum, David, Grainger, Joanne, White, Jonathan, Silver, Marianne
Published in Pain (Amsterdam) (01.03.2007)
Published in Pain (Amsterdam) (01.03.2007)
Get full text
Journal Article
P4‐236: The lympro® test: A biomarker for Alzheimer's disease using blood samples from clinically diagnosed Alzheimer's disease and cognitively intact subjects
Kirby, Louis, Bier, Colin, Jorgensen, Paul, Alexandrov, Vadim, Sabbagh, Marwan N.
Published in Alzheimer's & dementia (01.07.2015)
Published in Alzheimer's & dementia (01.07.2015)
Get full text
Journal Article
The lympro® test: A biomarker for Alzheimer’s disease using blood samples from clinically diagnosed Alzheimer’s disease and cognitively intact subjects
Kirby, Louis, Bier, Colin, Jorgensen, Paul, Alexandrov, Vadim, Sabbagh, Marwan N
Published in Alzheimer's & dementia (01.07.2015)
Published in Alzheimer's & dementia (01.07.2015)
Get full text
Journal Article
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease
Addy, Carol, Assaid, Chris, Hreniuk, David, Stroh, Mark, Xu, Yang, Herring, W Joseph, Ellenbogen, Aaron, Jinnah, H A, Kirby, Louis, Leibowitz, Mark T, Stewart, R Malcolm, Tarsy, Daniel, Tetrud, James, Stoch, S Aubrey, Gottesdiener, Keith, Wagner, John
Published in Journal of clinical pharmacology (01.07.2009)
Published in Journal of clinical pharmacology (01.07.2009)
Get more information
Journal Article
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Ferris, Steven, Galasko, Douglas, Kirby, Louis
Published in JAMA : the journal of the American Medical Association (27.08.2008)
Published in JAMA : the journal of the American Medical Association (27.08.2008)
Get full text
Journal Article
Biomarker Qualification in Alzheimer's Disease
Soares, Holly, Frank, Denise, Kirby, Louis, Dean, Robert, Berman, Robert, Risinger, Robert, Kelleher, Thomas, Gans-Brangs, Kathy, Cantillon, Marc
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
P2‐071: Biomarker Qualification in Alzheimer's Disease
Soares, Holly, Frank, Denise, Kirby, Louis, Dean, Robert, Berman, Robert, Risinger, Robert, Kelleher, Thomas, Gans‐Brangs, Kathy, Cantillon, Marc
Published in Alzheimer's & dementia (01.07.2011)
Published in Alzheimer's & dementia (01.07.2011)
Get full text
Journal Article
P3‐349: Scale rating variability in Alzheimer's disease clinical trials: A literature review
De Santi, Susan, Weber, Christopher J., Kirby, Louis C., Williams, Janet B.W.
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article
P3‐383: The MARQ‐AD: A new measure of interview quality in Alzheimer's disease trials
Weber, Christopher J., De Santi, Susan, Kirby, Louis C., Williams, Janet B.W.
Published in Alzheimer's & dementia (01.07.2010)
Published in Alzheimer's & dementia (01.07.2010)
Get full text
Journal Article